Risk stratification of persons on premixed insulin in Ramadan

J Pak Med Assoc. 2017 Nov;67(11):1771-1774.

Abstract

The International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance, has recently published practical guidelines on the management of diabetes and Ramadan .The risk stratification categorizes all persons wishing to fast into three groups, based upon potential risk. In spite of evidence to the contrary, all persons using premixed insulin are categorized as having high risk. In this article, we present data from randomized controlled trials, and discuss the placement of premixed insulin in the risk stratification framework.

Keywords: Insulin biphasic aspart (BIAsp), Biphasic lispro (LisproMix), Insulin degludec aspart (IDegAsp), Insulin detemir..

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Fasting / physiology*
  • Humans
  • Hypoglycemic Agents* / administration & dosage
  • Hypoglycemic Agents* / therapeutic use
  • Insulin* / administration & dosage
  • Insulin* / therapeutic use
  • Islam*
  • Middle Aged
  • Practice Guidelines as Topic
  • Risk Assessment

Substances

  • Hypoglycemic Agents
  • Insulin